BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
SUBSCRIBE
BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
BullScope
No Result
View All Result
Home Market News

McDonald’s earnings growth slows to 5% as currency masks flat constant-currency momentum

Moe Alsumidaie, MBA, MSF by Moe Alsumidaie, MBA, MSF
August 18, 2026
in Market News
0
74
SHARES
1.2k
VIEWS
Share on XShare on LinkedInShare on Facebook

McDonald’s reported second-quarter net income of $2,362 million, up 5 percent from $2,253 million a year earlier, with diluted earnings per share rising 6 percent to $3.32. But the headline gain masks a weaker underlying picture: in constant currencies, stripping out the $0.03 per share benefit from foreign exchange translation, earnings per share grew only 5 percent. For the six-month period, the company posted net income of $4,345 million, up 5 percent, and earnings per share of $6.10, up 6 percent, though constant-currency earnings per share growth slowed to 3 percent. The company provided no forward guidance in this filing.

Quarterly revenues reached $7,099 million, up from $6,843 million in the prior year quarter, a 4 percent increase that becomes 3 percent when currency translation is removed. Franchised revenues, which represent the bulk of the business model, grew 4 percent to $4,393 million, or 3 percent in constant currencies. Company-owned and operated sales grew 3 percent to $2,525 million, or flat in constant currencies. For the six-month period, revenues of $13,616 million compared to $12,799 million a year prior, a 6 percent reported gain that narrows to 6 percent in constant currencies. The company incurred restructuring charges of $52 million, or $0.06 per share, in the quarter as part of its “Accelerating the Organization” modernization effort.

What it means

McDonald’s growth is running substantially below its full-year 2025 revenue growth rate of 3.7 percent when currency effects are stripped away. The six-month constant-currency revenue growth of 6 percent appears stronger, but that figure includes an easier comparison to the first half of 2025 and masks a deceleration visible in the quarterly print. Franchised revenues, the company’s primary earnings driver, grew only 3 percent in constant currencies during the quarter, suggesting that underlying franchisee sales momentum is modest. Company-owned restaurant sales were flat in constant currencies, indicating no organic lift from the company’s own operations.

The currency tailwind is material and temporary. Foreign exchange translation added $0.03 per share in the quarter and $0.17 per share for the six months, accounting for roughly half of the reported earnings per share growth in the period. The company notes that most major currencies strengthened against the dollar, primarily the Euro and Australian Dollar. This benefit will reverse if those currencies weaken, and it masks the fact that underlying operational earnings growth is running at or below low single digits in constant currency terms.

BullScope TerminalWant the full evidence sheet behind pieces like this?The terminal runs the complete workup: MCDONALDS CORP and 500+ other names, on the same official data.See the evidence engine →

The open question is whether the modest constant-currency growth reflects a temporary softness in franchisee sales or a structural slowdown in the business. The document does not disclose comparable sales growth, which would indicate whether the growth in franchised revenues stems from new unit development or from same-store sales increases at existing locations. Without that metric, it is impossible to determine whether the company is growing through expansion or facing headwinds in like-for-like sales.

Source: the company’s 8-K filed 2026-08-04 with the SEC.

BullScope publishes impersonal research for a general audience. Nothing here is personalized investment advice, and nothing here is a recommendation to buy or sell any security. As of publication, neither BullScope nor its operator holds a position in any security, covered or otherwise; we do not trade at all, and we accept no compensation from any company we cover. When a conflict of interest exists, we do not publish: companies that compensate our operator in any capacity, or about which our operator could hold nonpublic information, are barred from coverage automatically, as described in the conflicts policy in our methodology. Figures come from company filings and public data through our published methodology; forecasts are conditional scenarios, not predictions and not promises. Markets carry risk, including loss of principal. Consider your own situation, or consult a licensed adviser, before acting on anything you read.
BullScope TerminalYou just read MCDONALDS CORP’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →
Moe Alsumidaie, MBA, MSF

Moe Alsumidaie, MBA, MSF

Moe Alsumidaie, MBA, MSF is the Chief Editor of BullScope. Trained in finance, with a Master of Science in Finance and an MBA, he spent years inside large public healthcare companies including Abbott, Genentech, and Roche, learning how the businesses behind the filings actually run. As a journalist and Chief Editor of The Clinical Trial Vanguard, his reporting has appeared in Applied Clinical Trials, The American Journal of Managed Care, and CNET, and has been cited in U.S. Supreme Court proceedings. At BullScope he brings those disciplines together: every note starts in the SEC filings, runs through published methodology, and shows its work.

Recommended For You

Adobe names Chakravarthy CEO as Narayen steps to executive chair

by Moe Alsumidaie, MBA, MSF
September 9, 2026
0

Adobe's board has named Anil Chakravarthy president and chief executive officer effective December 1, 2026, replacing Shantanu Narayen, who

Read moreDetails

AbbVie Reaffirms 2026 Guidance After Closing $10.9 Billion Apogee Acquisition

by Moe Alsumidaie, MBA, MSF
September 4, 2026
0

AbbVie completed its acquisition of Apogee Therapeutics for $10.9 billion in cash, adding two late-stage immunology assets to its pipeline

Read moreDetails

Moderna raises $2.6 billion in zero-coupon convertibles as revenue collapses, betting oncology turnaround

by Moe Alsumidaie, MBA, MSF
September 3, 2026
0

Moderna priced a $2.6 billion offering of convertible senior notes due 2032 on August 28, 2026, upsized from an initially planned $2.0 bill

Read moreDetails

Caterpillar renews three-year credit facility with unchanged $4 billion commitment as borrowing costs shift to SOFR

by Moe Alsumidaie, MBA, MSF
September 2, 2026
0

Caterpillar Inc. has executed a fifth amendment to its revolving credit agreement, dated August 27, 2026, maintaining a three-year facility

Read moreDetails

Boeing renews 364-day credit line as operating margin stays thin at 4.8%

by Moe Alsumidaie, MBA, MSF
September 1, 2026
0

Boeing has executed a new 364-day revolving credit agreement dated August 24, 2026, replacing its prior facility from August 25, 2025. The

Read moreDetails
Next Post

McDonald's names Skye Anderson as USA president, replacing Joe Erlinger after seven-year tenure

Please login to join discussion
BullScope
The Research Terminal
Run any stock through the BullScope evidence engine. Filings in, evidence out. Every number explains itself.
Open the Terminal
A BullScope product

Related News

Evidence Sheet: Zoetis (ZTS)

August 31, 2026

Vertex: One Drug Still Pays the Bills, But the Quarter Shows Something Else Beginning

August 26, 2026

Bank of America Is Priced for a Bank It Has Never Quite Been

August 14, 2026
BullScope

BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.

Prefer BullScope.ai on Google

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

No Result
View All Result
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.